Clovis completes public debt and stock offerings; nets $386mm
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Specialty Pharmaceuticals
- Convertible Debt
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.